|
LRRC57 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.00700000005283E-06 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.70509999997126E-06 |
| Normal-vs-Stage2 |
1.231780E-04 |
| Normal-vs-Stage3 |
8.197900E-04 |
| Normal-vs-Stage4 |
4.140400E-03 |
| Stage1-vs-Stage2 |
8.894200E-01 |
| Stage1-vs-Stage3 |
5.587400E-01 |
| Stage1-vs-Stage4 |
9.957000E-01 |
| Stage2-vs-Stage3 |
5.495400E-01 |
| Stage2-vs-Stage4 |
9.232600E-01 |
| Stage3-vs-Stage4 |
7.189800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
8.0392000001428E-07 |
| Normal-vs-AfricanAmerican |
2.978700E-04 |
| Normal-vs-Asian |
2.265900E-02 |
| Caucasian-vs-AfricanAmerican |
1.941240E-01 |
| Caucasian-vs-Asian |
9.790800E-01 |
| AfricanAmerican-vs-Asian |
6.562400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
8.39039999700475E-08 |
| Normal-vs-Female |
2.461900E-03 |
| Male-vs-Female |
1.987790E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
4.31739999999792E-05 |
| Normal-vs-Extreme_Weight |
3.13689999975608E-07 |
| Normal-vs-Obese |
7.8027000000036E-05 |
| Normal-vs-Extreme_Obese |
8.282900E-03 |
| Normal_Weight-vs-Extreme_Weight |
5.583200E-01 |
| Normal_Weight-vs-Obese |
7.634000E-01 |
| Normal_Weight-vs-Extreme_Obese |
8.715800E-01 |
| Extreme_Weight-vs-Obese |
3.206600E-01 |
| Extreme_Weight-vs-Extreme_Obese |
6.142800E-01 |
| Obese-vs-Extreme_Obese |
9.887200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.082100E-02 |
| Normal-vs-Age(41-60Yrs) |
8.2389000000016E-05 |
| Normal-vs-Age(61-80Yrs) |
3.66620000025186E-07 |
| Normal-vs-Age(81-100Yrs) |
4.597100E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.375200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.456770E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.442620E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.383600E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.803200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.702000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
5.66990000505641E-08 |
| Normal-VS-Type2 PRCC |
7.99670000000141E-05 |
| Normal-VS-KIRP CIMP |
2.895400E-01 |
| Normal-VS-Unclassified PRCC |
9.589300E-04 |
| Type1 PRCC-VS-Type2 PRCC |
6.895400E-01 |
| Type1 PRCC-VS-KIRP CIMP |
4.016100E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
4.412000E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.320980E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
7.236200E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
2.108200E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.68360000887924E-09 |
| Normal-vs-N1 |
4.435600E-04 |
| Normal-vs-N2 |
1.986050E-02 |
| N0-vs-N1 |
1.881840E-01 |
| N0-vs-N2 |
9.498400E-01 |
| N1-vs-N2 |
5.862800E-01 |
|
|
